Abstract
The dynamic movement of HIV-1 protease is an important feature for inhibitor design. The wide-open form of multi-drug resistant HIV-1 protease solved by our group exhibits an increase in flap distance. Stabilizing the protease flaps could be a strategy to overcome drug resistance. A peptidic inhibitor stabilizing the protease-inhibitor complex and a structural novel inhibitor targeting the wide-open form protease have been identified as a new scaffold for drug development.
Original language | English (US) |
---|---|
Pages (from-to) | 221-230 |
Number of pages | 10 |
Journal | Studia Universitatis Babes-Bolyai Chemia |
Issue number | 3 |
State | Published - Sep 2011 |
Keywords
- Drug design
- HIV-1 protease
- Multi-drug resistance
ASJC Scopus subject areas
- Chemistry(all)